ENT Disorder Clinical Trials

1 recruiting

ENT Disorder Trials at a Glance

65 actively recruiting trials for ent disorder are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 30 trials, with the heaviest enrollment activity in Boston, New York, and Chicago. Lead sponsors running ent disorder studies include Boston Children's Hospital, National Institute of Neurological Disorders and Stroke (NINDS), and Jorge Gonzalez-Martinez.

Browse ent disorder trials by phase

Treatments under study

About ENT Disorder Clinical Trials

Looking for clinical trials for ENT Disorder? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ENT Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ENT Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 65 trials

Recruiting

Genetic Characterization of Movement Disorders and Dementias

DementiaMovement Disorder
National Institute on Aging (NIA)12,000 enrolled1 locationNCT02014246
Recruiting

Phenotype/Genotype Correlations in Movement Disorders

Movement Disorder
National Institute of Neurological Disorders and Stroke (NINDS)2,500 enrolled1 locationNCT00018889
Recruiting

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

Movement Disorders
National Institute of Neurological Disorders and Stroke (NINDS)2,000 enrolled1 locationNCT00001208
Recruiting
Not Applicable

Non-invasive BCI-controlled Assistive Devices

Traumatic Brain InjuryHealthyMovement Disorders+6 more
University of Texas at Austin100 enrolled1 locationNCT05183152
Recruiting
Phase 2

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Adjustment Disorder
Reunion Neuroscience Inc100 enrolled26 locationsNCT07002034
Recruiting

Cortical Tracking of Speech in the First Year of Life

Language DevelopmentInfant DevelopmentLanguage Development Disorders+1 more
IRCCS Eugenio Medea50 enrolled1 locationNCT07531706
Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Movement DisordersParkinson DiseaseDystonia+1 more
Boston Scientific Corporation200 enrolled4 locationsNCT06553625
Recruiting
Not Applicable

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

Malignant Solid NeoplasmCancerHematopoietic and Lymphoid System Neoplasm+3 more
Mayo Clinic24 enrolled1 locationNCT07221409
Recruiting

Human Movement Database

Movement Disorder
National Institutes of Health Clinical Center (CC)7,500 enrolled1 locationNCT00001252
Recruiting

Natural History Protocol for Movement Disorders

TremorParkinson's DiseaseMovement Disorder
National Institute of Neurological Disorders and Stroke (NINDS)4,000 enrolled1 locationNCT05413291
Recruiting
Not Applicable

Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients

Movement DisordersParkinson's Disease
YangPan50 enrolled1 locationNCT07384442
Recruiting

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Movement DisordersParkinsons DiseaseNeurology
InSightec60 enrolled5 locationsNCT05539196
Recruiting
Not Applicable

Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers

MindfulnessMovement DisordersCaregivers+4 more
The University of Hong Kong200 enrolled1 locationNCT06821230
Recruiting

A Multicenter Pediatric Deep Brain Stimulation Registry

Movement DisordersNeurologic DisorderCerebral Palsy+6 more
Boston Children's Hospital100 enrolled1 locationNCT06585618
Recruiting

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

Movement DisordersMotor Neuron DiseaseHereditary Spastic Paraplegia+3 more
Boston Children's Hospital200 enrolled1 locationNCT05354622
Recruiting

A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes

EpilepsyMovement DisordersNeurologic Disorder+7 more
Boston Children's Hospital500 enrolled1 locationNCT06585605
Recruiting
Not Applicable

Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders

Movement Disorders
University of Alabama at Birmingham90 enrolled1 locationNCT04061135
Recruiting
Not Applicable

Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders

Movement Disorders
University of Pennsylvania100 enrolled1 locationNCT06848530
Recruiting
Phase 2

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Prostate CancerProstate CarcinomaProstate Neoplasm+12 more
Shehzad Basaria, M.D.60 enrolled1 locationNCT06957691
Recruiting
Phase 2

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Cancer of the BreastCancerAdjustment Disorder+8 more
Psyence Australia Pty Ltd87 enrolled3 locationsNCT07072728